Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Mannose-binding lectin deficiency is not associated with anti-Saccharomyces cerevisiae antibody in Korean Crohn's disease patients.

Kim YS, Kim YH, Ye BD, Park DW, Kim JW, Han DS.

Clin Chim Acta. 2014 Feb 15;429:206-11. doi: 10.1016/j.cca.2013.12.019. Epub 2013 Dec 25.

PMID:
24374090
2.

Low Mannan-binding lectin serum levels are associated with complicated Crohn's disease and reactivity to oligomannan (ASCA).

Schoepfer AM, Flogerzi B, Seibold-Schmid B, Schaffer T, Kun JF, Pittet V, Mueller S, Seibold F.

Am J Gastroenterol. 2009 Oct;104(10):2508-16. doi: 10.1038/ajg.2009.315. Epub 2009 Jun 16.

PMID:
19532127
3.

Increased titers of anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients with reduced H-ficolin levels but normal MASP-2 activity.

Schaffer T, Flogerzi B, Schoepfer AM, Seibold F, Müller S.

J Crohns Colitis. 2013 Feb;7(1):e1-10. doi: 10.1016/j.crohns.2012.02.013. Epub 2012 Mar 23.

PMID:
22445443
4.

Genetic variants of the mannan-binding lectin are associated with immune reactivity to mannans in Crohn's disease.

Seibold F, Konrad A, Flogerzi B, Seibold-Schmid B, Arni S, Jüliger S, Kun JF.

Gastroenterology. 2004 Oct;127(4):1076-84.

PMID:
15480986
5.

Association of deficiency for mannan-binding lectin with anti-mannan antibodies in Crohn's disease: a family study.

Seibold F, Boldt AB, Seibold-Schmid B, Schoepfer AM, Flogerzi B, Müller S, Kun JF.

Inflamm Bowel Dis. 2007 Sep;13(9):1077-82.

PMID:
17480019
6.

Mannan-binding lectin deficiency results in unusual antibody production and excessive experimental colitis in response to mannose-expressing mild gut pathogens.

Müller S, Schaffer T, Flogerzi B, Seibold-Schmid B, Schnider J, Takahashi K, Darfeuille-Michaud A, Vazeille E, Schoepfer AM, Seibold F.

Gut. 2010 Nov;59(11):1493-500. doi: 10.1136/gut.2010.208348. Epub 2010 Aug 3.

PMID:
20682699
7.

Low mannose-binding lectin (MBL) is associated with paediatric inflammatory bowel diseases and ileal involvement in patients with Crohn disease.

Kovacs M, Papp M, Lakatos PL, Jacobsen S, Nemes E, Polgar M, Solyom E, Bodi P, Horvath A, Molnar K, Szabo D, Cseh A, Muller KE, Dezsofi A, Arato A, Veres G.

J Crohns Colitis. 2013 Mar;7(2):134-41. doi: 10.1016/j.crohns.2012.03.008. Epub 2012 Apr 13.

PMID:
22504031
8.

Partial overlap of anti-mycobacterial, and anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease.

Müller S, Schaffer T, Schoepfer AM, Hilty A, Bodmer T, Seibold F.

World J Gastroenterol. 2008 Jun 21;14(23):3650-61.

9.
10.

Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn's disease and intestinal tuberculosis.

Makharia GK, Sachdev V, Gupta R, Lal S, Pandey RM.

Dig Dis Sci. 2007 Jan;52(1):33-9. Epub 2006 Dec 8.

PMID:
17160471
11.
12.

Mannose-binding lectin level and deficiency is not associated with inflammatory bowel diseases, disease phenotype, serology profile, and NOD2/CARD15 genotype in a large Hungarian cohort.

Papp M, Lakatos PL, Harsfalvi J, Farkas G, Palatka K, Udvardy M, Molnar T, Farkas K, Nagy F, Veres G, Lakatos L, Kovacs A, Dinya T, Kocsis AK, Papp J; Hungarian IBD Study Group, Altorjay I.

Hum Immunol. 2010 Apr;71(4):407-13. doi: 10.1016/j.humimm.2010.01.012. Epub 2010 Jan 26.

PMID:
20079790
14.
15.

Mannan binding lectin (MBL) gene polymorphisms are not associated with anti-Saccharomyces cerevisiae (ASCA) in patients with Crohn's disease.

Joossens S, Pierik M, Rector A, Vermeire S, Ranst MV, Rutgeerts P, Bossuyt X.

Gut. 2006 May;55(5):746. No abstract available.

16.

Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.

Gologan S, Iacob R, Preda C, Vadan R, Cotruta B, Catuneanu AM, Iacob S, Constantinescu I, Gheorghe L, Iobagiu S, Gheorghe C, Diculescu M.

J Gastrointestin Liver Dis. 2012 Mar;21(1):39-44.

17.

The impact of intestinal resection on serum levels of anti-Saccharomyces cerevisiae antibodies (ASCA) in patients with Crohn's disease.

Eser A, Papay P, Primas C, Pernicka E, Harrer M, Dejaco C, Novacek G, Lichtenberger C, Angelberger S, Kazemi L, Mikulits A, Vogelsang H, Reinisch W.

Aliment Pharmacol Ther. 2012 Jan;35(2):292-9. doi: 10.1111/j.1365-2036.2011.04932.x. Epub 2011 Dec 6.

18.

Pancreatic-specific autoantibodies to glycoprotein 2 mirror disease location and behaviour in younger patients with Crohn's disease.

Bogdanos DP, Roggenbuck D, Reinhold D, Wex T, Pavlidis P, von Arnim U, Malfertheiner P, Forbes A, Conrad K, Laass MW.

BMC Gastroenterol. 2012 Aug 6;12:102.

19.

Diagnostic utility of anti-Saccharomyces cerevisiae antibody (ASCA) and Interferon-γ assay in the differential diagnosis of Crohn's disease and intestinal tuberculosis.

Kim YS, Kim YH, Kim WH, Kim JS, Park YS, Yang SK, Ye BD, Jang BI, Jung SA, Jeen YT, Cheon JH, Choi YS, Choi JH, Kim BJ, Choi CH, Han DS.

Clin Chim Acta. 2011 Aug 17;412(17-18):1527-32. doi: 10.1016/j.cca.2011.04.029. Epub 2011 May 6.

PMID:
21575618
20.

Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment.

Teml A, Kratzer V, Schneider B, Lochs H, Norman GL, Gangl A, Vogelsang H, Reinisch W.

Am J Gastroenterol. 2003 Oct;98(10):2226-31.

PMID:
14572572
Items per page

Supplemental Content

Write to the Help Desk